Number of shares outstanding for Lexicon Pharmaceuticals (LXRX)

Number of shares outstanding as of July 2026 : 400,240,000

According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 400,240,000. At the end of 2026 the company had 400,240,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Lexicon Pharmaceuticals from 2015 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	0.40 B	10.13%
2025	0.36 B	0.54%
2024	0.36 B	47.59%
2023	0.24 B	29.78%
2022	0.18 B	26.75%
2021	0.14 B	21.69%
2020	0.12 B	15.14%
2019	0.10 B	0.33%
2018	0.10 B	0.31%
2017	0.10 B	1.48%
2016	0.10 B	0.41%
2015	0.10 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Thermo Fisher Scientific TMO	372,000,000	-7.06%	🇺🇸 USA
Illumina ILMN	153,000,000	-61.77%	🇺🇸 USA
Regeneron Pharmaceuticals REGN	104,000,000	-74.02%	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	100,600,000	-74.87%	🇺🇸 USA
Ligand Pharmaceuticals LGND	19,883,000	-95.03%	🇺🇸 USA
Esperion Therapeutics ESPR	251,353,086	-37.20%	🇺🇸 USA
Aerie Pharmaceuticals AERI	47,819,936	-88.05%	🇺🇸 USA
BioMarin Pharmaceutical BMRN	192,497,000	-51.90%	🇺🇸 USA
Eterna Therapeutics ERNA	31,680	-99.99%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions